Helus Pharma Inc.: MILLENNIUM MANAGEMENT LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Millennium Management LLC amended its Schedule 13G filing with the SEC regarding its stake in Helus Pharma Inc., under accession number 0001104659-26-126356. The amendment updates the hedge fund's previously reported beneficial ownership position in the pharmaceutical company. Schedule 13G filings are required of investors holding more than 5% of a company's shares, making the revision a signal of possible changes in Millennium's position size. Investors will watch for further 13G or 13D filings to gauge whether the fund is accumulating or trimming its stake.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Helus Pharma Inc., Millennium Management LLC